Automation Opportunities in Pharmacovigilance: An Industry Survey

  title={Automation Opportunities in Pharmacovigilance: An Industry Survey},
  author={Rajesh Ghosh and Dieter Kempf and Angela Pufko and Luisa Fernanda Barrios Martinez and Chris M. Davis and Sundeep Sethi},
  journal={Pharmaceutical Medicine},
  • Rajesh Ghosh, Dieter Kempf, +3 authors Sundeep Sethi
  • Published 2020
  • Computer Science, Medicine
  • Pharmaceutical Medicine
  • Background TransCelerate’s Intelligent Automation Opportunities (IAO) in Pharmacovigilance initiative has been working to evaluate various pharmacovigilance processes to facilitate systematic innovation with intelligent automation across the entire area. The individual case safety report (ICSR) process was the first process selected for evaluation because of its resource-intensive nature, risk of errors, and operational inefficiencies. Objectives TransCelerate’s IAO in Pharmacovigilance… CONTINUE READING
    4 Citations

    Figures, Tables, and Topics from this paper

    Explore Further: Topics Discussed in This Paper


    Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities
    • 3
    • PDF
    Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing
    • 13
    Why Are We Still Creating Individual Case Safety Reports?
    • 1
    Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation
    • 5
    • PDF
    Training Augmented Intelligent Capabilities for Pharmacovigilance: Applying Deep-learning Approaches to Individual Case Safety Report Processing
    • 5
    • PDF
    Pharmacovigilance in Crisis: Drug Safety at a Crossroads.
    • J. Price
    • Medicine
    • Clinical therapeutics
    • 2018
    • 7
    • PDF
    Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review
    • 54
    Detection of Pharmacovigilance‐Related Adverse Events Using Electronic Health Records and Automated Methods
    • 100
    Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter
    • 189
    • PDF